# Safety Assessment of Lemon Myrtle (Backhousia citriodora) Extract: 28-Day Oral Toxicity Study in Rats and In Vitro and In Vivo Genotoxicity Studies

**Authors:** Takashi Yamaguchi, Shinichi Honda, Toshihide Fujii, Ayumi Yamamoto, Keiichi Itoh, Maya Ueda, Shoji Masumori, Hiroshi Kubo

PMC · DOI: 10.3390/toxics14030213 · Toxics · 2026-02-28

## TL;DR

A study found that lemon myrtle extract is safe for oral consumption in rats and does not cause significant genetic damage.

## Contribution

This study provides new safety data on lemon myrtle water extract through in vitro and in vivo toxicity assessments.

## Key findings

- Lemon myrtle extract showed no adverse effects in a 28-day toxicity study in rats at up to 1000 mg/kg.
- Genotoxicity was observed in vitro but not in vivo, indicating no significant genetic risk in live animals.
- The extract was found to be non-genotoxic in mammalian erythrocyte assays.

## Abstract

The essential oil or extract of Lemon myrtle (Backhousia citriodora F. Muell.), belonging to the family Myrtaceae and the genus Backhousia, exhibits anti-inflammatory and antioxidant properties. However, limited information exists on the safety of water extracts from its leaves. The present study aimed to assess the safety of lemon myrtle water extract as a functional food by performing genotoxicity studies and repeated-dose oral toxicity. Although the bacterial reverse mutation test (Ames test) yielded positive results, in vivo mammalian erythrocyte micronucleus and alkaline comet assays yielded negative results. In a 28-day oral toxicity study, the extract was orally administered to male and female Crl:CD rats at doses of 0, 250, 500, and 1000 mg/kg bw/day. Notably, the extract induced no adverse effects, and the no-observed-adverse-effect level was 1000 mg/kg bw/day in male and female rats. Despite its genotoxicity in vitro, the extract did not exhibit genotoxicity in vivo. Moreover, no signs of toxicity were observed in the general toxicity study. Overall, these results suggest that lemon myrtle water extract does not pose a substantive genotoxic risk at practical oral exposure levels.

## Linked entities

- **Species:** Backhousia citriodora (taxon 39976)

## Full-text entities

- **Genes:** Got2 (glutamic-oxaloacetic transaminase 2) [NCBI Gene 25721] {aka ASPATA, mAAT}
- **Diseases:** corneal opacity (MESH:D003318), bone marrow toxicity (MESH:D001855), Toxicity (MESH:D064420), Pain (MESH:D010146), depression (MESH:D003866), Kidney cysts (MESH:D007674), sarcopenia (MESH:D055948), skin infections (MESH:D007239), injury to (MESH:D014947), inflammatory (MESH:D007249), skin irritation (MESH:D012871), muscle hypertrophy (MESH:C536106), carcinogenic (MESH:D011230), eye irritation (MESH:D005128), blood coagulation (MESH:D001778), weight gain (MESH:D015430), chromosomal aberration (MESH:D002869)
- **Chemicals:** NaOH (MESH:D012972), fat (MESH:D005223), free radical (MESH:D005609), 2-AA (MESH:C006593), potassium (MESH:D011188), triglyceride (MESH:D014280), acetic acid (MESH:D019342), sodium citrate (MESH:D000077559), hyperin (MESH:C021304), urea nitrogen (MESH:C530477), ketone bodies (MESH:D007657), eosin (MESH:D004801), citral (MESH:C007076), chloride (MESH:D002712), benzo[a]pyrene (MESH:D001564), 9-AA (MESH:D000585), lactate (MESH:D019344), gallic acid (MESH:D005707), 2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide (-), agarose (MESH:D012685), cholesterol (MESH:D002784), CD (MESH:D002104), phenobarbital (MESH:D010634), calcium (MESH:D002118), glucose (MESH:D005947), saline (MESH:D012965), essential oil (MESH:D009822), 5,6-benzoflavone (MESH:D019324), water (MESH:D014867), hematoxylin (MESH:D006416), Ames (MESH:C017501), CO2 (MESH:D002245), carbohydrates (MESH:D002241), casuarinin (MESH:C472513), myricitrin (MESH:C008577), cyclophosphamide (MESH:D003520), Flavonoids (MESH:D005419), quercitrin (MESH:C012526), Ethyl methanesulfonate (MESH:D005020), bilirubin (MESH:D001663), dimethyl sulfoxide (MESH:D004121), fiber (MESH:D004043), methanol (MESH:D000432), oils (MESH:D009821), creatinine (MESH:D003404), isoflurane (MESH:D007530), paraffin (MESH:D010232), AF-2 (MESH:D005668), NaN3 (MESH:D019810), Sodium (MESH:D012964), urobilinogen (MESH:D014558), AAF (MESH:D015073), diatomite (MESH:C033787), formalin (MESH:D005557)
- **Species:** Cavia porcellus (domestic guinea pig, species) [taxon 10141], Homo sapiens (human, species) [taxon 9606], Streptococcus mutans (species) [taxon 1309], Mus musculus (house mouse, species) [taxon 10090], Staphylococcus aureus (species) [taxon 1280], Rodentia (rodent, order) [taxon 9989], Backhousia citriodora (species) [taxon 39976], Clavinema sp. RF1 (species) [taxon 1699634], Salmonella enterica subsp. enterica serovar Typhimurium (no rank) [taxon 90371], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Escherichia coli (E. coli, species) [taxon 562], Rattus norvegicus (brown rat, species) [taxon 10116], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986]
- **Cell lines:** TA98 — Mus musculus (Mouse), Malignant neoplasms of the mouse mammary gland, Cancer cell line (CVCL_4315), LME-N — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_D911)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13029901/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC13029901/full.md

---
Source: https://tomesphere.com/paper/PMC13029901